Danijela Apostolovic1, Jelena Mihailovic2, Scott P Commins3, Michiel Wijnveld4, Maria Kazimirova5, Maria Starkhammar6, Hannes Stockinger4, Thomas A E Platts-Mills7, Tanja Cirkovic Velickovic2,8,9, Carl Hamsten1, Marianne van Hage1. 1. Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and University Hospital, Stockholm, Sweden. 2. Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Center of Excellence for Molecular Food Sciences, Belgrade, Serbia. 3. Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. 4. Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. 5. Institute of Zoology, Slovak Academy of Sciences, Bratislava, Slovakia. 6. Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden. 7. Asthma and Allergic Diseases Center, University of Virginia Health System, Charlottesville, VA, USA. 8. Ghent University Global Campus, Incheon, South Korea. 9. Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
To the EditorRed meat allergy known as mammalian meat allergy, caused by IgE antibodies against galactose-α-1,3-galacotse (α-Gal), is nowadays recognized worldwide and strong associations with tick bites have been identified for different tick species and geographic locations.[1] Time relationship between tick exposure and increased IgE levels to α-Gal has further supported the strong evidence that tick bites are the primary cause of the IgE antibodies.[2] All developmental stages of ticks can bite humans and in the US, high IgE levels to α-Gal following bites from larvae have been reported.[3] While we have previously demonstrated the presence of α-Gal in the gut of the European tick Ixodes ricinus[4], α-Gal-containing proteins in tick saliva from the South American, Japanese and European ticks, A. sculptum[5], Haemaphysalis longicornis[6] and Hyalomma marginatum[7], have recently been reported. However, the α-Gal-content of the I. ricinus proteome has not been investigated yet. Here we used allergenomics[8] and shotgun proteomics approaches to identify IgE-binding α-Gal carrying proteins in adult and larval stages as well as in saliva of I. ricinus ticks. Allergen-specific IgE antibody responses were assessed by ImmunoCAP (Thermo Fisher Scientific, Uppsala, Sweden) among 32 Swedish and 18 US mammalian meat allergicpatients to reveal differences in IgE reactivity between two geographical population groups. IgE- and α-Gal binding capacity, as well allergenicity of I. ricinus tick proteins were evaluated (details on methods and patients characteristics are presented in the Supporting information).Our data revealed that nearly all Swedish and American meat allergicpatients had IgE responses against both the larval and adult stages of I. ricinus and we noted that the four individuals IgE negative to I. ricinus had comparably low IgE levels to α-Gal (Table S1). Similarly to previous reports, moderate to high correlations between IgE to α-Gal and adult ticks were seen in the two patient groups (Figure S1).[4] Furthermore, the strong correlations between IgE reactivity to adult and larvae in both patient groups suggest that growth stages of I. ricinus ticks seems to be of less importance for the IgE recognition (Figure S1). In western-blot, IgE-reactive protein bands in the molecular weight range of 25–150 kDa in I. ricinus ticks were noted with comparable results for both tick stages using Swedish and American serum pools (Figure 1A and B respectively). To investigate whether the observed IgE reactivities were α-Gal related, the pools were pre-incubated with the α-Gal carrying glycoprotein bovine thyroglobulin prior to immunoblot analyses. The IgE binding to proteins from both adult and larval ticks was strongly diminished in Swedish as well as in US serum pools, revealing α-Gal as the main IgE target (Fig 1A and B lanes with α-Gal+) in both populations. Interestingly, proteins at the similar size were identified in I. ricinus saliva that bound red meat allergicpatients’ IgE and were recognized by the anti-α-Gal antibody (Figure 1C). Similar results have been reported for the analysis of saliva from the Japanese tick H. longicornis.[6] In addition, we investigated the IgE binding capacity with IgE inhibition ELISA where protein extract from I. ricinus was able to inhibit IgE binding to HSA-α-Gal by up to 77% (Fig S2). We also evaluated the allergenic potential of I. ricinus using blood from 14 mammalian meat allergicpatients and noted that adult ticks induced basophil activation in 13 patients (Figure 1D and Figure S3). The allergenic activity towards ticks was higher compared with HSA-α-Gal, however HSA-α-Gal showed to be more sensitive. This shows that I. ricinus protein epitopes also are of importance in basophil activation, which is in line with the IgE-binding capacity results (immunoblots and ELISA). When blood samples from four patients were stimulated with extract from I. ricinus larvae (Fig 1E), the allergenic activity was found to be similar to adult I. ricinus protein extract in three patients. None of the antigens activated basophils in two non-allergic individuals (Figure S3), indicating that the observed reactions were IgE-dependent. Basophil activation with adult I. ricinus protein extract was dose-dependent reaching 72.7% of CD63-positive cells (median, 34.4%; range, 7.5% to 72.7%,at concentration 50μg/ml) giving a sensitivity of 93%. Furthermore, a strong correlation between %CD63-positive basophils for adult I. ricinus protein extract and HSA-α-Gal (Fig S4) was noted, pointing out the dominant role of the α-Gal epitope in activating red meat allergicpatients’ basophils.
Fig. 1
IgE-binding activity and allergenic activity of I. ricinus proteins from adult and larvae in mammalian meat allergic patients. A) IgE immunoblot with the Swedish serum pool with (α-Gal+) and without inhibition with bovine thyroglobulin (α-Gal−) and B) IgE immunoblot with the US serum pool with (α-Gal+) and without inhibition with bovine thyroglobulin (α-Gal−); Lane 1- protein extract from adult I. ricinus ticks; Lane 2 - protein extract from larvae I. ricinus ticks; C) IgE binding to tick saliva proteins Lane i) with the Swedish serum pool Lane ii) and after inhibition with bovine thyroglobulin; Lane iii) with monoclonal anti-α-Gal binding; M-Molecular markers. D) Allergenic activity of 14 Swedish meat allergic patients on HSA-α-Gal and I.ricinus adult E) Allergenic activity of four Swedish meat allergic patient on I. ricinus adult and larvae
We used an allergenomics approach with 2D PAGE and 2D immunoblots together with mass spectrometry to identify α-Gal-carrying IgE binding proteins in adults and larvae ticks (Fig S5 and Fig S6, for details please see supporting information). Analysis of the obtained MS/MS spectra gave high identification scores to 43 protein accession numbers for adult and 37 for larvae from the Ixodida order (Table S2), grouped into six protein groups: vitellogenins, SERPIN, actin, α-2-macroglobulin, chitinase like-lectins and transport or channel forming proteins (Table 1). Comparing data from the 2D immunoblots with IgE binding (Fig S5A–C), and the anti-α-Gal antibody (Fig S5D) protein spots in the range of 75–100 kDa were shown to contain α-Gal carrying proteins. These proteins belonged to the vitellogenins and α-2-macroglobulin protein groups (Table 1). The other protein groups (actin, SERPIN, chitinase-like lectins and transport forming proteins) seem not to carry α-Gal. However, since these proteins possess IgE-binding properties and possibly allergenic activity, as shown in the basophil activation test with the higher response to I. ricinus extract compared to HSA-α-Gal, point to the fact that they most likely play a role in immune responses against ticks. Vitellogenins (isoforms 1–4), which was the major α-Gal-carrying IgE binding protein group, are produced in mid gut cells, fat bodies and salivary glands of ticks and are present in glycosylated and non-glycosylated forms. These carbohydrate-binding proteins have major function in tick reproduction.[9] The recognition of similar proteins in the 1D immunoblotting of saliva and identification of vitellogenins by mass spectrometry with high score (Table S3) indicated that they are abundantly present in tick saliva as well. Recently, Cabezas-Cruz and colleagues reported the expression of galactosyltransferase in Ixodes scapularis, an enzyme needed for the production of α-Gal.[10] Thus, taken together these data support that ticks produce the α-Gal epitope. The α-Gal-containing vitellogenin and α-2-macroglobulin are probably delivered into the host’s skin by tick bites and could presumably be involved in the induction of an anti-α-Gal immune response.
Table 1 -
Identified IgE and α-Gal binding proteins in Ixodes ricinus ticks
Protein group
IgE and α-Gal binding on 2D PAGE
I. ricinus adults
I. ricinus larvae
α-Gal
Spots from 2D
Vitellogenins
+
+
+
1–4,6–7,9–15
α-2-macroglobulin
−
+
+
13
SERPIN
+
+
−
8,16
Actin
+
+
−
8,16
Transport or channel forming proteins
+
−
−
5,8
Chitinase-like lectins
+
−
−
1,2,7
In conclusion, our results give new insight into mammalian meat allergy. Firstly, proteins from adults and larvae of the European tick I. ricinus are recognized by IgE from meat allergicpatients and have allergenic activity, which are α-Gal and tick protein specific. In addition, larvae were not fed on the host which supports that α-Gal carrying proteins originate from ticks. Moreover, I. ricinus tick saliva contains IgE binding α-Gal carrying proteins which by allergenomics revealed to be vitellogenins. The results support the strong relationship with tick bites for the development of mammalian meat allergy. Thus, red meat allergicpatients should be advised to avoid further tick bites.
Authors: Thomas A E Platts-Mills; Alexander J Schuyler; Anubha Tripathi; Scott P Commins Journal: Immunol Allergy Clin North Am Date: 2015-03-06 Impact factor: 3.479
Authors: C Hamsten; M Starkhammar; T A T Tran; M Johansson; U Bengtsson; G Ahlén; M Sällberg; H Grönlund; M van Hage Journal: Allergy Date: 2013-02-18 Impact factor: 13.146
Authors: Scott P Commins; Hayley R James; Libby A Kelly; Shawna L Pochan; Lisa J Workman; Matthew S Perzanowski; Katherine M Kocan; John V Fahy; Lucy W Nganga; Eva Ronmark; Philip J Cooper; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2011-03-31 Impact factor: 10.793
Authors: Ricardo Nascimento Araujo; Paula Ferreira Franco; Henrique Rodrigues; Luiza C B Santos; Craig S McKay; Carlos A Sanhueza; Carlos Ramon Nascimento Brito; Maíra Araújo Azevedo; Ana Paula Venuto; Peter J Cowan; Igor C Almeida; M G Finn; Alexandre F Marques Journal: Int J Parasitol Date: 2016-01-23 Impact factor: 3.981
Authors: Lourdes Mateos-Hernández; Margarita Villar; Angel Moral; Carmen García Rodríguez; Teresa Alfaya Arias; Verónica de la Osa; Francisco Feo Brito; Isabel G Fernández de Mera; Pilar Alberdi; Francisco Ruiz-Fons; Alejandro Cabezas-Cruz; Agustín Estrada-Peña; José de la Fuente Journal: Oncotarget Date: 2017-03-28
Authors: Thomas A E Platts-Mills; Scott P Commins; Tilo Biedermann; Marianne van Hage; Michael Levin; Lisa A Beck; Maria Diuk-Wasser; Uta Jappe; Danijela Apostolovic; Michael Minnicozzi; Marshall Plaut; Jeffrey M Wilson Journal: J Allergy Clin Immunol Date: 2020-02-10 Impact factor: 10.793
Authors: Margaret Shin Kim; Matthew D Straesser; Behnam Keshavarz; Lisa Workman; Emily C McGowan; Thomas A E Platts-Mills; Jeffrey M Wilson Journal: J Allergy Clin Immunol Pract Date: 2019-09-11
Authors: Danijela Apostolovic; Jeanette Grundström; Marija Perusko; M B Gea Kiewiet; Carl Hamsten; Maria Starkhammar; Marianne van Hage Journal: Clin Transl Allergy Date: 2021-12-15 Impact factor: 5.871
Authors: Mensiena B G Kiewiet; Marija Perusko; Jeanette Grundström; Carl Hamsten; Maria Starkhammar; Danijela Apostolovic; Marianne van Hage Journal: Clin Transl Allergy Date: 2022-01-17 Impact factor: 5.871
Authors: Jeffrey M Wilson; Behnam Keshavarz; Maya Retterer; Lisa J Workman; Alexander J Schuyler; Emily C McGowan; Charles Lane; Alaaddin Kandeel; Jane Purser; Eva Rönmark; Joseph LaRussa; Scott P Commins; Tina Merritt; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2020-06-06 Impact factor: 10.793